Advances in prostate specific antigen biosensors-Impact of nanotechnology

Publication date: Available online 28 January 2020Source: Clinica Chimica ActaAuthor(s): M. Negahdary, N. Sattarahmady, H. HeliAbstractProstate cancer is one of the most dangerous and deadly cancers in elderly men. Early diagnosis using prostate-specific antigen (PSA) facilitates disease detection, management and treatment. Biosensors have recently been used as sensitive, selective, inexpensive and rapid diagnostic tools for PSA detection. In this review, a variety of PSA biosensors such as aptasensors, peptisensors and immunesensors are highlighted. These use aptamers, peptides and antibodies in the biorecognition element, respectively, and can detect PSA with very high sensitivity via electrochemical, electrochemiluminescence, fluorescence and surface-enhanced Raman spectroscopy. To improve the sensitivity of most of these PSA biosensors, different nanostructured materials have played a critical role.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research